MSD (Sweden)

MSD (Sweden)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for MSD (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

78%


Total
Publications

133


Total Open
Publications

104


Total
Citations

9.9K


Open Access
Percentage

78%


Total
Publications

133


Total Open
Publications

104


Total
Citations

9.9K

Wikipedia

Website

download

Breakdown

30% 41% 6% 23%

Publisher Open

30%

Both

41%

Other Platform Open

6%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

51%OA Journal

OA Journal 51%

47

Hybrid 35%

32

No Guarantees 14%

13

Other Platform Open

Domain 73%

45

Institution 55%

34

Public 3%

2

Preprint 2%

1

Other Internet 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
45
Konstfack University of Arts, Crafts, and Design - Publications
Institution
22
DANS - Data Archiving and Networked Services
Institution
6
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
4
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
Figshare
Public
2
Europe PMC
Domain
2
Erasmus University, Rotterdam - RePub
Institution
2
Elsevier - Scopus
Institution
2
Utrecht University - Utrecht University Repository
Institution
1
1 / 3

Data updated 18 August 2025

Share

Share

Share